Healthcare -
Biotechnology - NASDAQ - US
$ 684.01
0.136 %
$ 73.9 B
Market Cap
16.93
P/E
REGN - REVENUE
Revenue REGN - Regeneron Pharmaceuticals, Inc.
13.1 B
LAST VALUE
-9.66%
2 YEAR CAGR
14.34%
5 YEAR CAGR
20.08%
10 YEAR CAGR